We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

179 hedge funds and large institutions have $2.29B invested in Aerie Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 74 increasing their positions, 53 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

187% more call options, than puts

Call options by funds: $28.9M | Put options by funds: $10.1M

57% more funds holding in top 10

Funds holding in top 10: 7 → 11 (+4)

40% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 53

25% more capital invested

Capital invested by funds: $1.83B → $2.29B (+$460M)

7% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 29

2% less funds holding

Funds holding: 182 → 179 (-3)

Holders
179
Holders Change
-3
Holders Change %
-1.65%
% of All Funds
4.06%
Holding in Top 10
11
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+57.14%
% of All Funds
0.25%
New
27
Increased
74
Reduced
53
Closed
29
Calls
$28.9M
Puts
$10.1M
Net Calls
+$18.8M
Net Calls Change
+$3.09M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$28.4M
2
PAMU
Pictet Asset Management (UK)
United Kingdom
+$19.3M
3
Neuberger Berman Group
Neuberger Berman Group
New York
+$14.3M
4
PHS
PFM Health Sciences
California
+$11.7M
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$11.6M

Top Sellers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
-$29.5M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$28.1M
3
Citadel Advisors
Citadel Advisors
Florida
-$10.3M
4
DM
Deerfield Management
New York
-$9.01M
5
AL
Appaloosa LP
New Jersey
-$8.25M
Name Holding Trade Value Shares
Change 		Change in
Stake
Walleye Trading
176
Walleye Trading
New York
$3 +$3.4K +56 New
PCG
177
Private Capital Group
Connecticut
$1 +$9.52K +157 New
AL
178
Appaloosa LP
New Jersey
– -$8.25M -169,799 Closed
GTC
179
Ghost Tree Capital
New York
– -$3.65M -75,000 Closed
NIP
180
Nicholas Investment Partners
California
– -$3.49M -71,871 Closed
NFA
181
Nationwide Fund Advisors
Ohio
– -$3.48M -71,609 Closed
Hudson Bay Capital Management
182
Hudson Bay Capital Management
Connecticut
– -$3.46M -71,210 Closed
BC
183
Broadfin Capital
New York
– -$3.15M -64,800 Closed
Point72 Asset Management
184
Point72 Asset Management
Connecticut
– -$2.52M -51,900 Closed
HCMT
185
Highland Capital Management (Texas)
Texas
– -$1.7M -35,000 Closed
HT
186
HAP Trading
New York
– -$902K -14,880 Closed
SSA
187
Schonfeld Strategic Advisors
New York
– -$574K -11,801 Closed
Tudor Investment Corp
188
Tudor Investment Corp
Connecticut
– -$535K -11,010 Closed
CSS
189
Cubist Systematic Strategies
Connecticut
– -$394K -8,106 Closed
California Public Employees Retirement System
190
California Public Employees Retirement System
California
– -$366K -7,525 Closed
FRM
191
Fox Run Management
Connecticut
– -$355K -7,300 Closed
AP
192
AHL Partners
United Kingdom
– -$337K -6,932 Closed
G
193
Gainplan
Michigan
– -$292K -6,000 Closed
Los Angeles Capital Management
194
Los Angeles Capital Management
California
– -$276K -5,670 Closed
PP
195
Paloma Partners
Connecticut
– -$271K -5,573 Closed
CG
196
Colony Group
Massachusetts
– -$261K -5,370 Closed
LCM
197
Laurion Capital Management
New York
– -$233K -4,800 Closed
SM
198
Sabby Management
Florida
– -$230K -4,726 Closed
LTFS
199
Ladenburg Thalmann Financial Services
Florida
– -$204K -4,200 Closed
QT
200
Quantbot Technologies
New York
– -$144K -2,981 Closed
5 6 7
8
9

AERI Hedge Fund Activity: Q4 2017 in Review

179 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q4 2017, worth a combined $2.29B — up 25% from $1.83B a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of AERI and 27 opened new positions — a net loss of 2 holders — while 53 trimmed existing stakes and 74 added.

The largest buyer was Morgan Stanley, adding an estimated $28.4M. The largest seller was Jennison Associates, cutting an estimated $29.5M.

  • 179 institutional investors held Aerie Pharmaceuticals (AERI) as of Q4 2017, down from 182 in Q3 2017.
  • Funds reported $2.29B of Aerie Pharmaceuticals stock for Q4 2017, up 25% quarter-over-quarter.
  • 27 funds opened new Aerie Pharmaceuticals positions in Q4 2017 and 29 closed out, a net change of -2 holders.
  • The largest Aerie Pharmaceuticals buyer in Q4 2017 was Morgan Stanley, an estimated $28.4M added.
  • The largest Aerie Pharmaceuticals seller in Q4 2017 was Jennison Associates, an estimated $29.5M sold.

Based on aggregated 13F filings for Q4 2017.